本页面由Tiger Trade Technology Pte. Ltd.提供服务

Adaptive Biotechnologies Corp

15.93
-0.5100-3.10%
盘后16.350.4200+2.64%18:40 EST
成交量:185.09万
成交额:2,958.64万
市值:24.50亿
市盈率:-40.62
高:16.35
开:16.20
低:15.74
收:16.44
52周最高:20.76
52周最低:6.26
股本:1.54亿
流通股本:1.17亿
量比:1.16
换手率:1.58%
股息:- -
股息率:- -
每股收益(TTM):-0.3922
每股收益(LYR):-0.3922
净资产收益率:-27.82%
总资产收益率:-6.79%
市净率:11.20
市盈率(LYR):-40.62

数据加载中...

2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/06

重要事件披露

Form 8-K - Current report
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

重要事件披露

Form 8-K - Current report
2026/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/30

重要事件披露

Form 8-K - Current report
2025/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities